Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/28/2014US8871265 Pharmaceutical formulation containing gelling agent
10/28/2014US8871264 Immediate release tablet formulations
10/28/2014US8871263 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
10/28/2014US8871257 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
10/28/2014US8871253 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
10/28/2014US8871251 Liposome and method for producing the same
10/28/2014US8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
10/28/2014US8871249 Medicated patch
10/28/2014US8871248 Compositions for treating biofilms and methods for using same
10/28/2014US8871246 Local administration of gallium compositions to treat pain
10/28/2014US8871245 Transdermal patch
10/28/2014US8871244 Vaginal suppository comprising lactic acid
10/28/2014US8871241 Injectable sustained release delivery devices
10/28/2014US8871240 Rapamycin coated expandable devices
10/28/2014US8871238 Medical devices and coatings therefore comprising biodegradable polymers with enhanced functionality
10/28/2014US8871236 Biocompatible polyacrylate compositions for medical applications
10/28/2014US8871228 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
10/28/2014US8871227 Process and formulation containing epothilones and analogs thereof
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/28/2014US8871219 Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS
10/28/2014US8871218 Infant nutritional compositions for preventing obesity
10/28/2014US8871217 Method for producing fucoxanthin
10/28/2014US8871210 Chemokine receptor antagonists and use thereof
10/28/2014US8871208 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof
10/28/2014US8871199 Compositions and methods to promote implantation and engrafment of stem cells
10/28/2014US8871190 Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
10/28/2014US8871189 MMP-targeted therapeutic and/or diagnostic nanocarriers
10/28/2014US8871187 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
10/28/2014US8871184 Topical tetracycline compositions
10/28/2014US8871183 Composition for promoting and maintaining oral health
10/28/2014US8871179 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
10/28/2014US8870934 Eye therapy system
10/23/2014US20140316333 Dissolving solid solution perforator patch for migraine treatment
10/23/2014US20140316151 Pasteurisation process for microbial cells and microbial oil
10/23/2014US20140316140 Dosing regimen for a selective s1p1 agonist
10/23/2014US20140316127 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
10/23/2014US20140316009 Intraocular pressure reduction with intracameral bimatoprost implants
10/23/2014US20140316007 Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them
10/23/2014US20140316005 Compositions for improved oxidative status in companion animals
10/23/2014US20140316004 Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites
10/23/2014US20140316003 Methods and compositions for treating or preventing attention deficit hyperactivity disorder
10/23/2014US20140316001 Enriched injectable emulsion containing selected fatty acid triglycerides
10/23/2014US20140315999 Use of prolyl hydroxylase inhibitors as a radioprotective drug for the lower gastrointestinal tract
10/23/2014US20140315997 Polymorphs of cddo ethyl ester and uses thereof
10/23/2014US20140315996 Use of isosorbide monoesters as antimicrobial active substances
10/23/2014US20140315995 Antioxidant Compositions and Methods of Using the Same
10/23/2014US20140315993 Natural Sweetener
10/23/2014US20140315991 Composition for treatment of epithelial tissue
10/23/2014US20140315990 Pkc activators and combinations thereof
10/23/2014US20140315980 Therapeutic or prophylactic agent for generalized pain syndrome
10/23/2014US20140315978 Compositions and Methods for Treatment of Prostate and Other Cancers
10/23/2014US20140315976 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
10/23/2014US20140315975 Apoptosis-inducing agent
10/23/2014US20140315973 Parp-1 inhibitors
10/23/2014US20140315964 Dosing regimen for a selective s1p1 receptor agonist
10/23/2014US20140315958 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate
10/23/2014US20140315953 Method and composition for treating migraines
10/23/2014US20140315948 Pharmaceutical Composition and Administrations Thereof
10/23/2014US20140315943 Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors
10/23/2014US20140315942 COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
10/23/2014US20140315941 Method of reducing cns and gastrointestinal side affects associated with long-term, dextromethorphan/low-dose quinidine combination therapy
10/23/2014US20140315940 Morphinan compounds
10/23/2014US20140315938 Compositions for controlling food intake and uses therefor
10/23/2014US20140315937 Sustained release formulation of nalbuphine
10/23/2014US20140315936 Apricitabine and pi combination therapy
10/23/2014US20140315934 Substituted benzylpyrazoles
10/23/2014US20140315933 Chemical compounds
10/23/2014US20140315932 Quinazolinone derivatives useful as vanilloid antagonists
10/23/2014US20140315930 Fast release solid oral compositions of entecavir
10/23/2014US20140315929 Hsp90 combination therapy
10/23/2014US20140315928 Substituted amide compounds
10/23/2014US20140315927 Inhibitors of HIV Replication
10/23/2014US20140315922 Method of treating parkinson's disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity
10/23/2014US20140315920 Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315911 Dihydropteridinones
10/23/2014US20140315910 Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
10/23/2014US20140315906 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
10/23/2014US20140315900 Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
10/23/2014US20140315894 Anti-cancer compounds targeting ral gtpases and methods of using the same
10/23/2014US20140315893 1,4- dihydropyridine derivatives with hsp modulating activity
10/23/2014US20140315892 Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders
10/23/2014US20140315890 Ivabradine hydrochloride form iv
10/23/2014US20140315886 Quinazolines as therapeutic compounds and related methods of use
10/23/2014US20140315879 Sulfonamide Derivatives
10/23/2014US20140315878 Chemical compounds
10/23/2014US20140315876 Beta-lactamase inhibitors
10/23/2014US20140315873 Animal feed including cationic cholesterol additive and related methods
10/23/2014US20140315872 Non-irritating testosterone emulsions
10/23/2014US20140315871 Topical pharmaceutical compositions of anti-microbial agents and anti-inflammatory agents
10/23/2014US20140315870 Composition comprising a glucocorticoid and a thiazolidinedione for inducing compelte adipogenic differentiation of mammalian stem cells
10/23/2014US20140315869 Therapeutic uses of ectoine
10/23/2014US20140315868 Organic compounds
10/23/2014US20140315867 Development of a new formulation overcoming thymus atrophy with concomitantly enhancement of anti-inflammatory effect of dexamethasone
10/23/2014US20140315866 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
10/23/2014US20140315865 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
10/23/2014US20140315864 Association of miliacin and polar lipids, particularly sphingolipids and/or phospholipids, for hair and scalp care
10/23/2014US20140315859 Proteasome Inhibitors as Ovoprotective Agents to Shield the Ovary from Chemotherapy Toxicity
10/23/2014US20140315857 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/23/2014US20140315855 Antidandruff Agent Sulfated Polysaccharides
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 7860